Volker Schäfer

Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug Targeting

Volker Schäfer, Hagen von Briesen, Reinhard Andreesen et al. · Pharmaceutical Research · 1992 · 140 citations

Impaired fibrinolysis in critically ill COVID-19 patients

Mirjam Bachler, Johannes Bösch, Daniel Stürzel et al. · British Journal of Anaesthesia · 2020 · 113 citations · Full text

Antimicrobial Effectiveness of Povidone-Iodine and Consequences for New Application Areas

K. Reimer, Thomas A. Wichelhaus, Volker Schäfer et al. · Dermatology · 2002 · 112 citations

Molecular Characterization of <i>rpoB</i> Mutations Conferring Cross-Resistance to Rifamycins on Methicillin-Resistant <i>Staphylococcus aureus</i>

Thomas A. Wichelhaus, Volker Schäfer, Volker Brade et al. · Antimicrobial Agents and Chemotherapy · 1999 · 112 citations · Full text

Mutation Position, Antibiotic Adjuvant, Molecular Biology +20

Biological Cost of Rifampin Resistance from the Perspective of <i>Staphylococcus aureus</i>

Thomas A. Wichelhaus, Boris Böddinghaus, Silke Besier et al. · Antimicrobial Agents and Chemotherapy · 2002 · 111 citations · Full text

Rpob Gene Accounting, Genetics, Staphylococcus Aureus +19